Susan R. Rheingold, MD

Susan R. Rheingold, MD, is medical director of the Oncology Outpatient Clinic and an attending physician with the Cancer Center at CHOP.

Areas of Expertise: Acute lymphoblastic leukemia, Complementary and alternative medicine, Medical education, Non-Hodgkins lymphoma
Locations: Main Campus
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

  • Background

    Susan R. Rheingold, MD, is an attending physician, Department of Pediatrics, Division of Oncology, at The Children’s Hospital of Philadelphia and associate professor in Pediatrics at the University of Pennsylvania School of Medicine.

    A 1992 graduate of the University of Pennsylvania School of Medicine, Dr. Rheingold completed a residency in pediatrics at John Hopkins Hospital in Baltimore, Maryland and a fellowship in Pediatric Hematology/Oncology at The Children’s Hospital of Philadelphia.

    After completing her training in 1999, Dr. Rheingold joined the staff of Children’s Hospital. She currently serves as the Medical Director of the Oncology outpatient clinic and director of Oncology Education for the Division of Oncology.

    Dr. Rheingold’s expertise is in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL). She serves on the Children’s Oncology Group’s Relapsed ALL Committee, Infant ALL Committee, and the Complementary Therapies Committee. Besides ALL, Dr. Rheingold maintains a special interest in experimental therapeutics and serves as a principal investigator for a Children’s Oncology Group national protocol.

    Other interests include complementary and alternative therapies, supportive care for oncology patients undergoing chemotherapy, medical education and rare childhood tumors. Dr. Rheingold is board certified in Pediatrics as well as Pediatric Hematology/Oncology.

  • Education and Training

    Medical School

    University of Pennsylvania School of Medicine, Philadelphia, Pa.

    Internship

    Johns Hopkins Hospital, Baltimore Md., Pediatrics

    Residency

    Johns Hopkins Hospital, Baltimore Md., Pediatrics

    Fellowship

    The Children's Hospital of Philadelphia, Philadelphia, Pa., Pediatric Hematology/Oncology

    Board Certification

    Pediatric Hematology-Oncology
    Pediatrics

  • Titles and Academic Titles

    Medical director, Oncology Outpatient Clinic

    Attending physician

    Associate professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

  • Centers and Programs
  • Research Interests

    Clinical research on relapsed leukemia
    Supportive Care Trials
    Experimental Drug Trials for ALL

  • Publications

    Books

    Chapters

    2010

    Rheingold SR. Oncologic emergencies. In: Davis DH, editor. Pediatric critical care: the requisites in pediatrics. Philadelphia: Elsevier Health Sciences-Mosby.

    Bailey C, Felix C, Rheingold SR. Acute lymphoblastic leukemia. In: Brodeur GM, Manno CS, editors. Pediatric hematology/oncology: the requisites in pediatrics. Philadelphia: Elsevier-Mosby.

    Teachey D, Bunin N, Rheingold SR. Germ cell tumors. In: Brodeur GM, Manno CS, editors. Pediatric hematology/oncology: the requisites in pediatrics. Philadelphia: Elsevier-Mosby.

    Fisher M, Rheingold SR. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Lippincott, Williams and Wilkins; 2010.

    Green A, Rheingold SR. Leukemia. In: Florin T, Ludwig S, editors. Netter's pediatrics. 1st ed. Philadelphia: Elsevier Health Sciences; 2010.

    Wolfe L, Scerbo J, Rheingold SR. Management of oncologic emergencies. In: Lanzowsky P, editor. Manual of pediatric hematology and oncology. 5th ed. Philadelphia: Elsevier Health Sciences. 2010.

    Sacks N, Wallace E, Bogucki B, Guzikowski V, Henry D, Rheingold SR. Hematology/oncology and hematopoietic transplant. In: Corkins M, editor. Pediatric nutrition support core curriculum. 1st ed. Silver Spring: American Society of Pediatric Enteral Nutrition (A.S.P.E.N.); 2010, p. 349.

    2009

    Rheingold SR, Neugut AI, Uldrick T, Meadows AT. Treatment-related secondary cancers. In: Hong WK, Bast RC, Hait WN, Kufe DW, Pollack RE, Weichselbaum RR, Holland JF, Frei EF, editors. Holland-Frei Cancer medicine. 8th ed. Shelton: People's Medical Publishing House; 2009. p. 1915.

    2006

    Rheingold SR, Neugut AI, Meadows AT. Treatment-related secondary cancers In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Hait W, Hong WK, Holland JF, Frei E, editors. Cancer medicine. 7th ed. Shelton: People's Medical Publishing House-USA; 2006.

    2005

    Rheingold SR, Lange BJ. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 1202-30.

    Rheingold SR, Lange BJ. Oncologic emergencies. In: Fleisher GR, Ludwig S, editors. Textbook of pediatric emergency medicine. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005. p. 1239-74.

    Abstracts

    2010

    Insogna I, Sacks N, Simpson C, Commander L, Wallace C, Baniewicz D, et al. Improvement of outpatient oncology clinic efficiency utilizing standardized clinic tracking data [abstract]. ASPHO, Pediatr Blood Cancer, 2010, 183.

    2009

    Sacks N, Pietsch J, Sandler E, Rogers PC, Wallace B, Rheingold SR. Pilot study of proactive enteral tube feedings in children with high risk tumors [abstract]. ASPHO, Pediatr Blood Cancer, 2009, 211.

    Papers

    2011

    Paisley MA, Kang TI, Insogna IG, Rheingold SR. Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy. Pediatr Blood Cancer. 2011 July 1;56(7):1088-91. doi: 10.1002/pbc.22939. Epub 2011 Feb 25. Cited in PubMed: PMID 21360653. Read the abstract

     

    2010

    Commander LA, Seif AE, Insogna IG, Rheingold SR. Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory pediatric T-cell lymphoblastic leukemia and lymphoma. Br J Hematol 2010 Aug;150(3):345-51. Epub 2010 May 26. Cited in PubMed: PMID 20528871. Read the abstract

    Seif AE, Reilly AF, Rheingold SR. Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric. J Pediatr Hematol Oncol 2010 Nov: 32(8):e349-52. Cited in PubMed: PMID 20962675. Read the abstract

    Seif AE, Sutter JA, Rheingold SR. Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy. Pediatr Blood Cancer 2010 Aug;55(2):386-9. Cited in PubMed: PMID 20582966. Read the abstract

    Ladas E, Kroll D, Oberlies N, Cheng B, Hughes D, Rheingold SR, et al. A randomized controlled pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer, 2010;116(2):506-13. Cited in PubMed: PMID 20014183. Read the abstract

    Jeha S, Razzouk B, Rytting M, Rheingold SR, Albano E, Kadota R, et al. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia. J Clin Oncol, 2009 Sep 10; 27(26):4392-7. Epub 2009 Aug 3. Cited in PubMed: PMID 19652076. Read the article

    Rheingold SR, Hogarty MD, Blaney SM, Zwiebel J; Sauk-Schubert C, Chandula R, et al. A phase I trial of G3139, a Bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a children’s oncology group study. J Clin Oncol, 2007;25(12):1512-18. Cited in PubMed: PMID 17442993. Read the abstract

    Posters and Presentations

    2010

    Rheingold SR. Phase I trial of temsirolimus in combination with standard salvage chemotherapy [presentation]. Children's Oncology Group National Meeting; 2010 Mar; Los Angeles, CA.

    Rheingold SR. mTOR inhibition: from the bench to the bedside [invited lecture]. Vanderbilt-Ingram Cancer Center, Vanderbilt University; 2010 Mar; Nashville, TN.

    2009

    Rheingold SR. Management of relapsed acute lymphoblastic leukemia [invited lecture]. The Chemotherapy Foundation Symposium XXVII, Innovative Cancer Therapy for Tomorrow, Mount Sinai Medical Center; 2009 Nov; New York, NY.

    Rheingold SR. Update of childhood leukemia and lymphoma [invited lecture]. 5th Annual Focus on Leukemia, Lymphoma, and Myeloma, The Leukemia & Lymphoma Society; 2009 Nov; Philadelphia, PA.

    Rheingold SR. Evaluation of mTOR inhibitors in childhood ALL and NHL [invited lecture]. Children's Oncology Group National Meeting; 2009 Sep; Dallas, TX.

    Rheingold SR. An oncologist's approach to acute leukemia in infants [invited lecture]. Chief Rounds, Cooper University Hospital; 2009 Jun; Camden, NJ.

    Rheingold SR. mTOR inhibitors: from the bench to the bedside [invited lecture]. Hematology/Oncology Grand Rounds, Children's Hospital of Los Angeles; 2009 Feb; Los Angeles, CA.

    Rheingold SR. Challenges in curing childhood acute lymphoblastic leukemia [invited lecture]. Adult/Pediatric ALL Interest Group; 2009 Jan; Philadelphia, PA.

  • Editorial and Academic Positions

    Editorial positions

    Reviewer 

    British Journal of Hematology
    Journal of Pediatrics
    Journal of Pediatric Hematology/Oncology
    Pediatric Blood & Cancer